1. Home
  2. HLX vs ABCL Comparison

HLX vs ABCL Comparison

Compare HLX & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$8.71

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$7.08

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
ABCL
Founded
1979
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
HLX
ABCL
Price
$8.71
$7.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$11.50
$8.40
AVG Volume (30 Days)
1.4M
6.5M
Earning Date
04-22-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
$876,561,000.00
$75,128,000.00
Revenue This Year
$2.05
N/A
Revenue Next Year
$5.46
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
3.60
160.56
52 Week Low
$5.52
$2.75
52 Week High
$10.75
$6.86

Technical Indicators

Market Signals
Indicator
HLX
ABCL
Relative Strength Index (RSI) 37.13 70.75
Support Level $8.58 $3.32
Resistance Level $10.54 N/A
Average True Range (ATR) 0.30 0.49
MACD -0.08 0.11
Stochastic Oscillator 16.10 87.27

Price Performance

Historical Comparison
HLX
ABCL

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. The Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S., and it also has its presence in North Sea, Brazil, Asia Pacific, West Africa, and Other.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: